Concentric wall thickening (n = 17) | Non-concentric wall thickening (n = 5) | Statistical significance (p-value) | |
---|---|---|---|
Males | 12 (71 %) | 3 (60 %) | 1.000 |
Age (years) | 49.4 (44.1–53.9) | 62.2 (51.2–63.8) | 0.055 |
Hypertension | 5 (29 %) | 4 (80 %) | 0.115 |
EDWTmax (mm) | 14.4 (13.3–16.5) | 17.3 (16.5–31.0) | 0.017 |
LVEDVI (ml/m2) | 83.6 (74.1–108.6) | 78.0 (76.4–94.8) | 0.845 |
LVEF (%) | 59.3 (56.3–64.6) | 57.4 (56.0–66.7) | 0.969 |
LVMI (g/m2) | 91.5 (77.2–103.1) | 132.7 (93.1–174.7) | 0.066 |
LVPMI (g/m2) | 4.8 (3.6–6.4) | 5.6 (4.9–9.1) | 0.147 |
LVTPMI ml/m2) | 13.8 (10.1–17.0) | 20.2 (15.5–22.6) | 0.066 |
Scar as percentage of total LV myocardium (%) | 2.8 (1.3–7.0) | 14.7 (7.1–21.8) | 0.026 |
Scar as percentage of apical myocardium (%) | 0.3 (0.0–1.1) | 18.9 (14.4–40.6) | 0.003 |
Scar as percentage of mid-ventricular myocardium (%) | 2.0 (1.0–5.2) | 9.1 (6.8–21.9) | 0.014 |
Scar as percentage of basal myocardium (%) | 4.4 (1.1–8.1) | 5.3 (1.4–13.8) | 0.411 |